SHL Medical opens US$220M autoinjector plant in South Carolina

USA—SHL Medical, a Swiss company specializing in drug delivery systems, has officially inaugurated its new US$220 million autoinjector production facility in North Charleston, South Carolina.

This significant expansion strengthens the company’s global presence and marks a major milestone in its operations.

 According to a press release dated April 1, the state-of-the-art facility will manufacture autoinjectors designed to deliver medications for treating endocrine and metabolic disorders, musculoskeletal diseases, and other therapeutic conditions.

Spanning 360,000 square feet, the fully automated plant is equipped with cutting-edge technology for medical device injection molding.

It is also expected to create 300 new jobs in the region, contributing to local economic growth.

SHL Medical’s CEO and chairman, Ulrich Faessler, highlighted the importance of this development, stating that U.S.-based production represents a critical step in the company’s global expansion strategy.

He emphasized that with this facility, along with their existing site in Taiwan and an upcoming plant in Switzerland, SHL will become the only autoinjector manufacturer operating across three continents.

This global reach will allow the company to better serve its customers by being closer to key markets.

The North Charleston facility complements SHL’s existing assembly, labeling, and packaging operations, which are located in Deerfield Beach, Florida.

Initially announced in 2022, the project reflects SHL’s commitment to scaling up its production capabilities to meet growing demand for drug delivery devices.

In addition to expanding its infrastructure, SHL secured financial backing in 2022 from a group of investors that included Stockholm-based EQT and ATHOS, as well as other co-investors.

This funding has enabled the company to pursue its ambitious growth plans in the drug delivery sector.

Looking ahead, SHL aims to deliver an impressive 1.5 billion devices to customers worldwide this year.

With its advanced facilities and strategic investments, the company is well-positioned to maintain its leadership in providing innovative drug delivery solutions on a global scale.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.